InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+177.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Oltmans Curtis Gale, Vice-Président Senior, Conseiller Juridique. Insider active across 2 companies, notably Fulcrum Therapeutics, Inc.. In total, 3 filings have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €46k. Activity tracked since 28 June 2021. The latest transaction was filed on 15 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Oltmans Curtis Gale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
3,452 股@ US$12.9282.2% 占其流量Common StockSEC:0001193125-25-322740:0
49,020 股0Common StockSEC:0001104659-21-152195:0
1,088 股@ US$9.0117.8% 占其流量Common StockSEC:0000899243-21-026556:0
标准退出：2021年9月26日 (T+90)
3 条申报中的 3 条
About Oltmans Curtis Gale
Oltmans Curtis Gale serves as Senior Vice President and General Counsel at Fulcrum Therapeutics, Inc. and Avenue Therapeutics, Inc. In this role, he oversees legal and regulatory matters while contributing to the overall strategy of the company. With expertise in corporate law, he plays a key role in managing legal risks and compliance. His experience in the pharmaceutical sector allows him to provide valuable insights into the company's strategic decisions.
